These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12132030)

  • 1. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett).
    Michalis LK; Rees MR; Patsouras D; Katsouras CS; Goudevenos J; Pappas S; Sourla E; Kolettis T; Sioros L; Zotou P; Gartzou-Matsouka P; Sideris DA
    Cardiovasc Intervent Radiol; 2002; 25(5):423-9. PubMed ID: 12132030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of Vasoseal and Angioseal closure devices in patients undergoing coronary angiography and angioplasty.
    Shammas NW; Rajendran VR; Alldredge SG; Witcik WJ; Robken JA; Lewis JR; McKinney D; Hansen CA; Kabel ME; Harris M; Jerin MJ; Bontu PR; Dippel EJ; Labroo A
    Catheter Cardiovasc Interv; 2002 Apr; 55(4):421-5. PubMed ID: 11948884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro).
    Chamberlin JR; Lardi AB; McKeever LS; Wang MH; Ramadurai G; Grunenwald P; Towne WP; Grassman ED; Leya FS; Lewis BE; Stein LH
    Catheter Cardiovasc Interv; 1999 Jun; 47(2):143-7; discussion 148. PubMed ID: 10376492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient tolerance and resource utilization associated with an arterial closure versus an external compression device after percutaneous coronary intervention.
    Juergens CP; Leung DY; Crozier JA; Wong AM; Robinson JT; Lo S; Kachwalla H; Hopkins AP
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):166-70. PubMed ID: 15390237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
    Duffin DC; Muhlestein JB; Allisson SB; Horne BD; Fowles RE; Sorensen SG; Revenaugh JR; Bair TL; Lappe DL
    J Invasive Cardiol; 2001 May; 13(5):354-62. PubMed ID: 11385148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
    J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of access site in patients treated with platelet glycoprotein IIb/IIIa inhibitors in the era of closure devices.
    Assali AR; Sdringola S; Moustapha A; Ghani M; Salloum J; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):1-5. PubMed ID: 12508187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of two arterial closure devices, Angioseal and Perclose, in coronary catheter interventions].
    Zhou ZJ; Cui K; Cao SP; Huang Z; Guo ZG; Xiu JC; Hou YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1767-70. PubMed ID: 22027787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of the angioseal vascular closure device post antegrade puncture.
    Looby S; Keeling AN; McErlean A; Given MF; Geoghegan T; Lee MJ
    Cardiovasc Intervent Radiol; 2008; 31(3):558-62. PubMed ID: 18253787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network meta-analysis of studies comparing closure devices for femoral access after percutaneous coronary intervention.
    Iannaccone M; Saint-Hilary G; Menardi D; Vadalà P; Bernardi A; Bianco M; Montefusco A; Omedè P; D'Amico S; Piazza F; Scacciatella P; D'Amico M; Moretti C; Biondi-Zoccai G; Gasparini M; Gaita F; D'Ascenzo F
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):586-596. PubMed ID: 30045086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of hemostatic puncture closing device for hemostasis and early ambulation after coronary angiography and angioplasty: results of a multicenter trial].
    Magosaki N; Hosoda S; Kawagishi N; Yamaguchi T; Sakatani H; Haze K; Itagane H; Otsuka M; Nobuyoshi M; Yokoi H
    J Cardiol; 1999 Sep; 34(3):131-8. PubMed ID: 10500973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of a hemostatic device with percutaneous collagen application (VasoSeal) compared to a mechanical compression system (Compressar) after transfemoral catheterization of patients suffering from arterial occlusive disease].
    Neudecker A; Manke C; Lenhart M; Zorger N; Paetzel C; Feuerbach S; Link J
    Rofo; 2003 May; 175(5):676-81. PubMed ID: 12743862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and effectiveness of repeat arterial closure using the AngioSeal device in patients with hepatic malignancy.
    Hieb RA; Neisen MJ; Hohenwalter EJ; Molnar JA; Rilling WS
    J Vasc Interv Radiol; 2008 Dec; 19(12):1704-8. PubMed ID: 18951046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular complications with newer generations of angioseal vascular closure devices.
    Applegate RJ; Sacrinty M; Kutcher MA; Gandhi SK; Baki TT; Santos RM; Little WC
    J Interv Cardiol; 2006 Feb; 19(1):67-74. PubMed ID: 16483343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restick following initial Angioseal use.
    Applegate RJ; Rankin KM; Little WC; Kahl FR; Kutcher MA
    Catheter Cardiovasc Interv; 2003 Feb; 58(2):181-4. PubMed ID: 12552540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoseal hemostasis following coronary interventions with abciximab.
    Lunney L; Karim K; Little T
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():2B-3B. PubMed ID: 10745610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory response to femoral arterial closure devices: a randomized comparison among FemoStop, AngioSeal, and Perclose.
    Jensen J; Saleh N; Jensen U; Svane B; Jönsson A; Tornvall P
    Cardiovasc Intervent Radiol; 2008; 31(4):751-5. PubMed ID: 18398639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial comparing StarClose and AngioSeal vascular closure devices in a district general hospital--the SCOAST study.
    Veasey RA; Large JK; Silberbauer J; Paul G; Taggu W; Ellery S; Rathore VS; Lloyd GW; Patel NR; Sulke AN
    Int J Clin Pract; 2008 Jun; 62(6):912-8. PubMed ID: 18479284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity: an independent risk factor for insufficient hemostasis using the AngioSeal vascular closure device after antegrade puncture.
    Minko P; Katoh M; Gräber S; Buecker A
    Cardiovasc Intervent Radiol; 2012 Aug; 35(4):775-8. PubMed ID: 21792734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated ambulation after vascular access closure device.
    Brancheau D; Sarsam S; Assaad M; Zughaib M
    Ther Adv Cardiovasc Dis; 2018 May; 12(5):141-144. PubMed ID: 29421959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.